Table 2 Clinical and biochemical baseline data in the three tested groups (represented as (mean ± SD))

FEV₁(% predicted)

55.76 ± 20.02

53.53 ± 14.97

57.54 ± 20.51

0.714^Θ

FVC (% predicted)

54.45 ± 16.6

55.27 ± 14.27

58.58 ± 21.53

0.578^Θ

FEV₁/FVC Ratio

87.42 ± 10.69

85.19 ± 12.11

83.1 ± 12.98

0.306^Θ

6MWD (m)

232.71 ± 77.1

237.35 ± 85.58

229.05 ± 95.41

0.922^Θ

Desaturation (% SpO₂)

9.46 ± 6.32

10.13 ± 8.95

9.73 ± 8.1

0.941^Θ

KL-6 (U/ml)

723.22 ± 218.18

615.99 ± 146.66

669.44 ± 191.34

0.069^Θ

ESR (mm)

58.1 ± 26.67

56.12 ± 27.97

59.96 ± 27.91

0.841^Θ

CRP (mg/L)

18.26 ± 18.77

20.1 ± 18.79

19.48 ± 20.62

0.925^Θ

Blood Glucose (mg/dl)

109.46 ± 35.55

104.12 ± 29.61

109 ± 48.13

0.823^Θ

Systolic Blood Pressure (mmHg)

120.71 ± 9.63

120.91 ± 11.282

126.41 ± 12.028

0.052^Θ

Diastolic Blood Pressure (mmHg)

79.57 ± 10.387

80 ± 9.186

83.85 ± 10.542

0.137^Θ

ALT (U/L)

27.03 ± 17.64

27.82 ± 29.54

26.97 ± 14.87

0.983^Θ

AST (U/L)

25.03 ± 9.56

25.36 ± 15.82

26.41 ± 11.3

0.882^Θ